<DOC>
	<DOCNO>NCT02343575</DOCNO>
	<brief_summary>Delirium often encounter psychiatric diagnosis general hospital , incidence 85 % intensive care unit ( ICU ) set significant consequence patient ' morbidity mortality . Currently , although FDA approve , antipsychotic often consider first-line pharmacological treatment . However , limitation use , include side effect lack efficacy . Valproic acid ( VPA ) one alternative time used patient limited case series data appear helpful tolerate . VPA provide relief agitation pose threat safety recovery patient . Moreover , mechanistically address neurochemical cellular abnormality inherent delirium ( NMDA-antagonist , anti-dopaminergic , GABAergic , anti-inflammatory , anti-apoptotic , histone deacetylase inhibitor property , among others ) . The purpose study evaluate efficacy tolerability VPA first know u randomize control trial .</brief_summary>
	<brief_title>Valproic Acid Treatment Hyperactive Mixed Delirium ICU</brief_title>
	<detailed_description>The investigator plan investigate efficacy tolerability schedule VPA compare placebo need basis ( PRN ) haloperidol ( back-up arm ) treatment hyperactive mixed delirium . Patients randomize schedule VPA placebo ( normal saline ) arm flexible PRN dose haloperidol . Thus , investigator plan learn time delirium resolution patient treat VPA versus placebo ; percentage patient respond VPA versus placebo ; tolerability VPA versus placebo . If addition schedule VPA prove shorten time delirium resolution compare placebo , lead less use haloperidol , and/or few side effect , would provide important addition limit evidence-based repertoire delirium treatment . Moreover , pilot study would pave way big randomize control trial power detect effect size .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>patient 18 year age older admit surgical ICU diagnose hyperactive mixed delirium hypoactive delirium primary team think patient appropriate participate oral access ( PO NGT ) nonEnglish speak contraindication study medication pregnant woman woman childbearing age document contraception QTc = great 480 hepatic dysfunction decrease platelet platelet dysfunction bleed disorder , current major bleed history NMS , epilepsy , PD diagnosis schizophrenia , bipolar disorder schizoaffective disorder warfarin carbapenems delirium due alcohol withdrawal treat antipsychotic 48 hour prior study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Hyperactive delirium</keyword>
	<keyword>Mixed delirium</keyword>
	<keyword>Anti-psychotic</keyword>
	<keyword>Haldol</keyword>
	<keyword>Valproic Acid</keyword>
</DOC>